Is EXOZ or FBIO more undervalued in 2026?

CirclFi compares eXoZymes Inc. (EXOZ) and Fortress Biotech, Inc. (FBIO) using 13 institutional-grade valuation models. EXOZ has a Quality of Company score of 4.5/10 while FBIO scores 5.9/10.

Which is a better buy — EXOZ or FBIO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do EXOZ and FBIO valuations compare?

EXOZ at $9.72 and FBIO at $2.81 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

EXOZ vs FBIO Valuation Comparison 2026 — Intrinsic Value Analysis

EXOZ

Biotechnology

eXoZymes Inc.

Quality

4.5

out of 10

Value Trap

—

Price

$9.72

Last close

Models

6/13

Active

FBIO

Biotechnology

Fortress Biotech, Inc.

Quality

5.9

out of 10

Value Trap

SAFE

Price

$2.81

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	EXOZ Fair Value	EXOZ Upside	FBIO Fair Value	FBIO Upside
Bayesian DCF	Intrinsic	$2.58	-73.4%	$4.87	+73.4%
Earnings Power Value	Intrinsic	—	—	$3.96	+70.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.29	-97.0%	$4.01	+42.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for EXOZ vs FBIO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EXOZ vs FBIO — Which Stock Is More Undervalued?

FBIO scores higher with a 5.9/10 quality rating vs EXOZ's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing eXoZymes Inc. (EXOZ) and Fortress Biotech, Inc. (FBIO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EXOZ currently trades at $9.72 with a QOC of 4.5/10, while FBIO trades at $2.81 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).